Pfizer has entered a November strategic alliance with Ochsner Health System, as the drug firm attempts to develop digital tools for clinical trials, which remain one of the most expensive aspects of drug development. The companies said they expect the tools to streamline clinical trials for patients, researchers and providers. Pfizer has previously entered into partnerships to develop digital health capabilities, inking a deal with China’s jianke.com in multi-year.
Pfizer has entered a multi-year strategic alliance with Ochsner Health System, as the drug firm attempts to develop digital tools for clinical trials, which remain one of the most expensive aspects of drug development. The companies said they expect the tools to streamline clinical trials for patients, researchers and providers. Pfizer has previously entered into partnerships to develop digital health capabilities, inking a deal with China’s jianke.com in November.